AstraZeneca, FibroGen hit another roxadustat setback as FDA panel calls for more safety data
15th July 2021 Uncategorised 0 AstraZeneca, FibroGen hit another roxadustat setback as FDA panel calls for more safety data
esagonowsky
Thu, 07/15/2021 – 16:36
More: AstraZeneca, FibroGen hit another roxadustat setback as FDA panel calls for more safety data
Source: fierce